Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Thrombosis, Deep Vein: early-phase trial registry

1 of 1 indexed Thrombosis, Deep Vein trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Thrombosis, Deep Vein: 1 US clinical trial tracked, 1 recruiting.

Thrombosis, Deep Vein is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mercator MedSystems, running 1 of these trials.

Enrollment posture brief

Registry condition thrombosis-deep-vein

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Thrombosis, Deep Vein (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Thrombosis, Deep Vein

Thrombosis, Deep Vein lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thrombosis, Deep Vein on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Thrombosis, Deep Vein is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Thrombosis, Deep Vein records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Perivascular sham Combination
1 trials
Perivascular dexamethasone Combination
1 trials

US sites by state

Facility locations filed on Thrombosis, Deep Vein trials. A trial with sites in several states counts in each.

Virginia 1 trials
Pennsylvania 1 trials
Oklahoma 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
North Carolina 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Thrombosis, Deep Vein page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Thrombosis, Deep Vein trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mercator MedSystems sponsors the most Thrombosis, Deep Vein trials on record, review their full trial history before evaluating a specific study. See Mercator MedSystems's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thrombosis, Deep Vein condition card totals 1 registered trials; most-linked intervention Perivascular sham; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.